Category Archives: Avastin

Featured Stories
FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

FDA Announces Final Decision to Revoke Avastin Breast Cancer Decision

As expected, the U.S. Food & Drug Administration (FDA) had revoked its approval of Avastin as a treatment for breast cancer. In doing so, the FDA concluded that Avastin was not a safe or effective treatment for breast cancer. “This … Continue reading

Posted in Avastin, Pharmaceuticals |

Doctors Reconsider Avastin Eye Injections amid Infection Fears

Several clusters of blinding eye infections have some doctors rethinking the common practice of using < "">Avastin off-label to treat wet, age related macular degeneration. According to a report from The New York Times, some physicians are now worried that … Continue reading

Posted in Avastin, Pharmaceuticals |

Avastin Label Updated to Include Ovarian Failure, Other Side Effects

The label for the cancer drug < "">Avastin (bevacizumab) has been updated to include a warning that it may impact a woman’s fertility. According to a notice posted on the U.S. Food & Drug Administration (FDA) website, the Avastin label … Continue reading

Posted in Avastin, Pharmaceuticals |

VA Says No Avastin Eye Injections Pending Infection Probe

The Department of Veterans Affairs (VA) has stopped using the cancer drug < "">Avastin to treat age-related, wet macular degeneration, following reports that this off-label use of Avastin may have caused potentially-blinding eye infections in some patients. According to a … Continue reading

Posted in Avastin, Pharmaceuticals |

Medicare Urged to Consider Avastin for Eye Treatments, Despite Infection Risk

< "">Avastin could soon become Medicare’s drug-of-choice for treating wet, age-related macular degeneration, even though it has been associated with serious eye infections when used this way. Moving from Lucentis to Avastin would allow Medicare to save half a billion … Continue reading

Posted in Avastin, Pharmaceuticals |

Five More Avastin Eye Infections Reported, This Time in Los Angeles

Five more patients have suffered serious, blinding eye infections following injections of the cancer drug < "">Avantis to treat wet macular degeneration. According to The New York Times, all five of the infections occurred last month in people who received … Continue reading

Posted in Avastin, Pharmaceuticals |

Avastin Eye Injections Caused Infections, Blindness

The cancer drug < "">Avastin has caused a cluster of serious eye infections in the Miami, Florida area, according to the U.S. Food & Drug Administration (FDA). According to a warning to healthcare professionals issued yesterday, a pharmacy had repacked … Continue reading

Posted in Avastin, Pharmaceuticals |

FDA Panel Rejects Avastin for Breast Cancer a Second Time

A panel of Food & Drug Administration (FDA) advisors has again rejected < "">Avastin as a treatment for breast cancer. In a 6-0 vote, the FDA oncology panel ruled for a second time that Avastin is not clinically beneficial, effective … Continue reading

Posted in Avastin, Pharmaceuticals |

Recent Avastin Woes Prompt Breast Cancer Group to Change Its Position

A major advocacy group for breast cancer patients is backing away from promoting the controversial drug, < "">Avastin, for use in new patients. According to a report in The Wall Street Journal, the new stance by the Susan G. Komen … Continue reading

Posted in Avastin, Pharmaceuticals | Tagged , , , , , , |

Avastin Study Finds Increased Death Risk

Cancer patients treated with < "">Avastin are 50 percent more likely to die than those treated with chemotherapy alone, according to a new study. The same study found that when patients are treated with Avastin and certain chemotherapy drugs – … Continue reading

Posted in Avastin | Tagged , , , , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.